COO
Status-Quo-PlayerCooper Companies (The)
$71.70
+0.67%
as of 13 Apr
Power Core
Cooper's moat is the prescribing behavior of eye care professionals, which creates a demand-side lock-in that operates upstream of the consumer and insulates the company from direct-to-consumer disruption.
Direction of Movement
Upward on Share Gains, Myopia, and Integration Maturation
ROC 200
+0.6%
COO
Cooper Companies (The)
$71.70
+0.67%
as of 13 Apr
DCF Fair Value: $48.63
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, multifocal, toric, and specialty lenses under brands such as Proclear, Biofinity, MyDay, and Clariti. It serves contact lens wearers worldwide with high-quality products and practitioner support, maintaining a significant presence in the contact lens market. CooperSurgical focuses on reproductive health, fertility, and women's care, providing a broad range of medical devices that cover the entire IVF cycle, along with products like Paragard, the only hormone-free IUD available in the US. The company advances health outcomes for women, babies, and families through its diversified offerings in medical devices, fertility, and genomics. Founded in 1958 and headquartered in San Ramon, California, The Cooper Companies, Inc. plays a key role in the healthcare sector, particularly in eyecare and reproductive medicine.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,000
Website
https://www.coopercos.com